Could Genomics Influence Prostate Cancer Treatment?
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Category: AACR
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career...